Subject category:
Strategy and General Management
Published by:
IBS Case Development Center
Length: 8 pages
Data source: Published sources
Topics:
AstraZeneca; Cholesterol-lowering drugs (statins); Blockbuster drugs; Crestor; Lipitor; Baycol controversy; Negative sentiments; Pfizer's marketing; Merck's Zocor; Bristol-Myers Squibb's Pravachol; Marketing budgets; FDA approvals (Federal Drug Administration); Merck's Vytorin; The Lancet; Clinical tests
Share a link:
https://casecent.re/p/20075
Write a review
|
No reviews for this item
This product has not been used yet
Share a link:
https://casecent.re/p/101885
Write a review
|
No reviews for this item
This product has not been used yet
Share a link:
https://casecent.re/p/119412
Write a review
|
No reviews for this item
This product has not been used yet
Not yet registered with us?
Register today to place orders, create search alerts, submit cases to us ... and much more.
Registered educators and trainers, and their support staff, can also access preview copies, instructor materials and see product reviews and usage.